Navigation Links
Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
Date:2/13/2008

ar Biology Business.

-- 3M Food Collaboration. On November 8, Gen-Probe announced that 3M

informed the Company it no longer intends to fund the companies'

collaboration to develop rapid molecular assays for the food testing

industry. The collaboration has since been formally terminated.

Despite the termination, Gen-Probe received milestone payments of

$2 million in the fourth quarter of 2007 associated with achieving

technological feasibility for potential food testing assays.

Gen-Probe retains the rights to commercialize these assays.

-- First MilliPROBE(TM) Test. On January 8, Millipore and Gen-Probe

announced the launch of the first product from their collaboration to

create faster, sensitive, more robust tests for detecting contaminants

in pharmaceutical and biotechnology manufacturing processes. The

MilliPROBE system is the first solution of its kind for

biopharmaceutical manufacturing. It combines Millipore's leading,

industry-accepted sample prep methodologies with Gen-Probe's advanced,

proven nucleic acid technologies to deliver both speed and sensitivity

in one microbial screening tool. The MilliPROBE system uses Real-Time

Transcription-Mediated Amplification (RT TMA) technology to detect

targeted microbial contamination within hours compared to the days or

weeks usually required to generate results using traditional

culture-based methods. The collaboration's first MilliPROBE assay

targets the bacterium Pseudomonas aeruginosa and is designed as an

in-process, early warning system to provide faster, more effective

detection of the bacterium in purified water used during drug

production.

-- Purchase of Blood Screening Manufacturing Plant. On February 1,

Gen-Probe purchased for $15.7 million its blo
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Carl Hull Named President and Chief Operating Officer of Gen-Probe
2. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
3. Gen-Probe to Webcast Three Upcoming Presentations
4. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
5. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
6. Imagenetix Inc. Reports Third Fiscal Quarter Results
7. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
8. Maxygen Reports Fourth Quarter and Year End 2007 Financial Results
9. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
10. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
11. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):University of the Basque Country research on plankton at Urdaibai 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3The impact of the diffusion of maize to the Southwestern United States 29 11 Responders May Be At Raised Myeloma Risk 54040 19 11 Responders May Be At Raised Myeloma Risk 54040 29 11 Responders May Be At Raised Myeloma Risk 54040 3PLC Systems Reports Second Quarter 2009 Results 3B Announces Timing for Release of Preliminary Data From Italian Study of RenalGuard 54038 1PLC Systems Reports Second Quarter 2009 Results 3B Announces Timing for Release of Preliminary Data From Italian Study of RenalGuard 54038 2PLC Systems Reports Second Quarter 2009 Results 3B Announces Timing for Release of Preliminary Data From Italian Study of RenalGuard 54038 3PLC Systems Reports Second Quarter 2009 Results 3B Announces Timing for Release of Preliminary Data From Italian Study of RenalGuard 54038 4PLC Systems Reports Second Quarter 2009 Results 3B Announces Timing for Release of Preliminary Data From Italian Study of RenalGuard 54038 5PLC Systems Reports Second Quarter 2009 Results 3B Announces Timing for Release of Preliminary Data From Italian Study of RenalGuard 54038 6Leading Turkish Hospital Group Selects Varian Equipment for Major Expansion 54036 1Leading Turkish Hospital Group Selects Varian Equipment for Major Expansion 54036 2Leading Turkish Hospital Group Selects Varian Equipment for Major Expansion 54036 3